Skip to main content
Year archive

NurExone Biologic Inc — 2017 filings

All 23 regulatory filings released by NurExone Biologic Inc (NRX) in 2017, sourced directly from the official regulator.

23 Filings
2017 Period
2017 filings (23)
Filing Released Lang
News release - English.pdf
Regulatory Filings
2017-12-07 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2017-11-29 English
Interim financial statements/report – English.PDF
Regulatory Filings
2017-11-29 English
News release - English.pdf
Regulatory Filings
2017-11-29 English
News release - English.pdf
Regulatory Filings
2017-11-15 English
News release - English.pdf
Regulatory Filings
2017-09-14 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2017-08-17 English
Interim financial statements/report – English.pdf
Regulatory Filings
2017-08-17 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2017-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2017-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2017-05-30 English
Notice.pdf
Regulatory Filings
2017-04-07 English
Other securityholders documents - English.pdf
Regulatory Filings
2017-04-06 English
News release - English.pdf
Regulatory Filings
2017-04-03 English
Material change report - English.pdf
Regulatory Filings
2017-03-30 English
News release - English.pdf
Regulatory Filings
2017-03-30 English
News release - English.pdf
Regulatory Filings
2017-03-22 English
Consent of qualified person (NI 43-101) - English.pdf
Regulatory Filings
2017-03-22 English
Filing statement - English.pdf
Regulatory Filings
2017-03-22 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2017-02-16 English
Annual MD&A - English.pdf
Regulatory Filings
2017-02-16 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2017-02-16 English
News release - English.pdf
Regulatory Filings
2017-02-03 English